• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX MITRAL CONFORM 25/33; HEART VALVE MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX MITRAL CONFORM 25/33; HEART VALVE MECHANICAL Back to Search Results
Model Number ONXMC-25/33
Device Problem Insufficient Information (3190)
Patient Problem Thrombus (2101)
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to initial report,"2 incidents of explantation due to thrombosis.One approx.12 months ago and one approx.18 months ago.(note: 'date of incident' field, above, is approx.Only) reported to rep during field visit with surgeon in india (b)(6) 2017."it was reported that one patient died after having experienced symptoms for over one week.The other patient had valve explanted and replaced by other mechanical valve (not on-x)." multiple attempts have been made for additional information.However, all attempts at correspondence have gone unmet.Note it is unclear based on the initial information which patients experienced explant, thrombosis or death.This investigation will be relegated to the thrombosis events.
 
Manufacturer Narrative
A review of the available information was performed.An anecdotal report from the surgeon to the sales representative on (b)(6) 2017 reported one on-x mitral valve replacement (mvr) recipient experienced symptoms of thrombosis about a year ago and a second mvr patient about 18 months ago.Both patients underwent explantation of their mitral on-x valves.Neither valve was identified by serial number, so model(s) and size(s) could not be verified.One of these patients died after over a week of symptoms and the other received a new (non-on-x) valve replacement after explantation of the original on-x valve.It was not indicated which patient lived and which did not.The status of anticoagulation therapy is completely unknown in both cases.The valves were not available for examination.We do not know the genesis of either thrombus.There is no medical record to consult as this is only word-of-mouth.We do not know the actual cause of death of the one patient nor how long he/she survived post-explantation.With the paucity of specificity, we can only evaluate these events in broad statistical terms.While thrombosis is a recognized potential complication associated with prosthetic mitral valve replacement, as are explantation and death [instructions for use], its occurrence is relatively rare.Objective performance criteria report an historical thrombosis incidence of 0.8% per valve-year for all rigid prosthetic valves (b)(4).There is not enough specific, nor objective, information available to establish any cause for either the thromboses or the reported death; so we do not know what, if any, relationship the valves may or may not have had with the events reported.A definitive root cause for this event is not possible and based on the limited available information.No further action necessary.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
 
Event Description
According to initial report,"2 incidents of explantation due to thrombosis.One approx.12 months ago and one approx.18 months ago.(note: 'date of incident' field, above, is approx.Only) reported to rep during field visit with surgeon in (b)(6) 2017."it was reported that one patient died after having experienced symptoms for over one week.The other patient had valve explanted and replaced by other mechanical valve (not on-x)." multiple attempts have been made for additional information.However, all attempts at correspondence have gone unmet.Note it is unclear based on the initial information which patients experienced explant, thrombosis or death.This investigation will be relegated to the thrombosis events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX MITRAL CONFORM 25/33
Type of Device
HEART VALVE MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd
kennesaw, GA 30144
MDR Report Key6877395
MDR Text Key86703531
Report Number1649833-2017-00067
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberONXMC-25/33
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date08/25/2017
Date Manufacturer Received08/25/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-